My Insurance Won’t Cover GLP-1 Drugs. What Now?

Table of Contents

Within the complicated world of well being care and insurance coverage, it pays to pursue each attainable possibility. You may dispute insurance coverage denials, however the worth a pharmacy affords is just not essentially the bottom worth yow will discover.

seek for reductions

For years, the price of semaglutide and tirzepatide was extensively reported to be round $1,000 per 30 days. Whereas money costs should be excessive at your native pharmacy counter, drug firms have just lately made their merchandise accessible at a lot decrease costs in different methods.

Lilly (Mounjaro, Zepbound), the maker of tirzepatide, at the moment affords the drug for $349 to $499 per 30 days when bought on its web site or at Walmart.

Novo Nordisk, the maker of semaglutide (Ozempic, Wegovy), affords most doses of the load loss and diabetes drug for $350 per 30 days. New decrease costs can be found on the producer’s web site or by means of choose companions like WW and Costco.

In November 2025, each producers introduced that costs for medicines bought by means of government-run web sites would turn into even decrease within the coming years.

In some instances, these low-cost medicine are administered utilizing vials and syringes relatively than easier-to-use prefilled injection pens.

Moreover, drug firms could provide coupons and financial savings playing cards that may considerably scale back your out-of-pocket prices over the course of a 12 months. Nevertheless, not everybody can take part in these packages, nor can they be used indefinitely.

Disputing Lack of Protection

Bridget Roberts, 37, received re-admission to Zepbound by means of persistence. It began when the Pottsgrove, Pennsylvania, resident acquired a letter saying her insurance coverage firm not coated GLP-1.

“At first, I felt like I used to be doomed,” she says. “One thing was lastly beginning to click on and I used to be extra alive than ever, and so they wished to take that away from me.”

Roberts pushed again. She referred to as a number of occasions to attraction, however was instructed a unique story every time. Her persistence lastly paid off. She spoke with a consultant from her insurance coverage firm who instructed her to hunt a brand new pre-authorization from her physician. This approval could also be required by the physician earlier than the insurance coverage firm agrees to cowl the remedy.

“It was like she was talking in code, like she knew one thing I did not know,” Roberts says. She and her physician have been equally confused as a result of she already had prior authorization, however when her physician filed a brand new request, her medicine was authorized.

Swap diagnostics

Different GLP-1 customers have been in a position to preserve insurance coverage protection by altering the prognosis indicated on their prescription.

“Many GLP-1s are FDA-approved for functions past simply weight reduction, resembling kind 2 diabetes, cardiovascular danger discount, and even stroke prevention in sure populations,” says Supriya Rao, M.D., a gastroenterologist and weight problems knowledgeable at Integrative Gastroenterology Consultants in Boston.

In case your insurance coverage firm cancels protection for a weight reduction drug, the identical drug could also be coated for one more situation, resembling sleep apnea, coronary heart illness, or steatohepatitis, which is a liver situation associated to metabolic dysfunction. A brand new prescription for a brand new situation “may make the distinction between full denial and full protection,” Dr. Rao says.

Dr. Brianna Johnson-Lovett, an endocrinologist at Nebraska Drugs and director of the American Board of Weight problems Drugs, affords some examples. “If somebody has heart problems and is overweight or chubby, we will prescribe Wigoby primarily based on that indication,” says Dr. Johnson-Lovett. “Individuals with reasonable to extreme obstructive sleep apnea and weight problems might be prescribed Zepbound for his or her signs.”

Nevertheless, switching diagnoses doesn’t assure protection. “Even when the FDA’s indications for prescribing the drug are met, insurance coverage could resolve to not cowl the drug,” Johnson-Lovett says.